2025-08-11 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA) based on the provided data, presented in English with numbers, analysis, and a final summary.

## Natera Inc. (NTRA) Stock Analysis

**Company Overview:** Natera Inc. is a diagnostics company focused on cell-free DNA testing.

**1. Relative Performance vs. S&P 500 (VOO):**

*   **Ticker:** NTRA
*   **NTRA Cumulative Return:** 135.49%
*   **VOO Cumulative Return:** 84.01%
*   **Absolute Difference:** 51.48%
*   **Range (Max-Min):** 630.1 - (-29.0)
*   **Current Spread:** 32.6
*   **Relative Spread:** 9.3

**Analysis:** NTRA has significantly outperformed the S&P 500 (VOO) over the period examined. However, the "Relative Spread" of 9.3 suggests that the *current* outperformance is relatively low compared to its historical range against the VOO. This means while NTRA is still ahead, its lead isn't as strong as it has been in the past.

**Alpha/Beta Analysis Table:**

| Year       | CAGR   | MDD    | Alpha   | Beta  | Cap(B) |
|------------|--------|--------|---------|-------|--------|
| 2015-2017  | -6.0%  | 62.4%  | -9.0%   | -3.5  | 1.2    |
| 2016-2018  | 29.0%  | 80.1%  | 33.0%   | 0.2   | 1.9    |
| 2017-2019  | 159.0% | 80.1%  | 136.0%  | 0.1   | 4.6    |
| 2018-2020  | 530.0% | 80.1%  | 503.0%  | 0.1   | 13.7   |
| 2019-2021  | 355.0% | 62.9%  | 306.0%  | 0.0   | 12.8   |
| 2020-2022  | -119.0% | 62.9%  | -126.0%  | 0.0   | 5.5    |
| 2021-2023  | -482.0% | 69.9%  | -502.0%  | 0.9   | 8.6    |
| 2022-2024  | -75.0%  | 70.6%  | -101.0%  | 0.9   | 21.7   |
| 2023-2025  | 84.0%  | 76.2%  | 35.0%   | 0.7   | 20.9   |

*   **CAGR & MDD:** The CAGR (Compound Annual Growth Rate) shows significant volatility, with periods of massive growth followed by substantial declines. The MDD (Maximum Drawdown) is consistently high, indicating significant risk.
*   **Alpha:** Alpha is the excess return compared to the benchmark, and NTRA's Alpha mirrors the CAGR trend, showing both strong outperformance and significant underperformance periods.
*   **Beta:** Beta values are generally low (close to 0 or 1), suggesting NTRA's price is not strongly correlated with the S&P 500.  Some years showing negative beta (-3.5) which is very unusual and suggest inverse correlation with market at that time.
*   **Cap(B):** Represents Market Capitalization in Billions of dollars. It can be seen that Capital continues to increase despite of sharp CAGR decreases. This is due to NTRA business development strategy in the industry.

**2. Recent Price Action:**

*   **Closing Price:** 151.95
*   **Last Market Data:** Price 151.95, Previous Close 141.08, Change: 7.7%
*   **5-Day Moving Average:** 141.57
*   **20-Day Moving Average:** 141.3968
*   **60-Day Moving Average:** 155.0803

**Analysis:** The stock price jumped significantly (7.7% increase), closing at 151.95. The 5-day and 20-day moving averages are below the current price, suggesting a short-term upward trend. However, the 60-day moving average is higher, which may act as resistance.

**3. Indicators:**

*   **Market Risk Indicator (MRI):** 0.3323 (Low Risk)
*   **RSI:** 62.31 (Approaching Overbought)
*   **PPO:** 1.0725 (Positive Momentum)
*   **Hybrid Signal:** cash_1%_Buy 80% of cash (40 shares - Caution - MRI:0.33)
*   **20-Day Relative Spread Change:** 0.7 (+) Short-term increase
*   **Expected Return:** 264.9% (Long-Term, vs. S&P 500)

**Analysis:**
*   **MRI:** The Market Risk Indicator is currently in the "Low Risk" range, suggesting a relatively stable market environment for the stock.
*   **RSI:** The RSI (Relative Strength Index) is at 62.31, approaching the overbought territory (typically above 70). This indicates that the stock may be overvalued in the short term and could be due for a correction.
*   **PPO:** The PPO (Percentage Price Oscillator) is positive at 1.0725, indicating that the shorter-term moving average is above the longer-term moving average, suggesting upward momentum.
*   **Hybrid Signal:** The hybrid signal suggests to buy 80% cash with caution.
*   **Relative Spread Change:** The 20-day relative spread change is positive, which suggests that the stock has been outperforming the S&P 500 over the past 20 days.
*   **Expected Return:** The exceptionally high expected return (264.9%) is a projection of *long-term* outperformance against the S&P 500 if a buy-and-hold strategy is employed. This should be viewed with caution and considered a best-case scenario.
*   **Sudden Price Change:** The recent 7.7% price jump indicates a significant event or news catalyst driving the stock. This volatility should be factored into any investment decision.

**4. Recent News & Significant Events:**

*   **August 10, 2025:** Major business developments, regulatory changes, or market events.
*   **August 8, 2025:** Analyst discussions on recent performance and outlook.
*   **August 11, 2025:** Notable stock volatility.
*   **August 9, 2025:** Market experts highlighting both risks and opportunities.

**Analysis:** The recent news suggests that NTRA is experiencing significant activity, which is contributing to the observed volatility. Investors should investigate these specific events to understand their potential impact on the company.

**5. Recent Earnings Analysis:**

| Date       | EPS   | Revenue  |
|------------|-------|----------|
| 2025-08-08 | -0.74 | 0.55 B$  |
| 2025-05-09 | -0.50 | 0.50 B$  |
| 2024-11-12 | -0.26 | 0.44 B$  |
| 2024-08-09 | -0.30 | 0.41 B$  |
| 2025-08-08 | -0.30 | 0.41 B$  |

**Analysis:** The company is reporting losses per share (negative EPS). While revenue is generally increasing, the losses persist, indicating a need for improved cost management or increased profitability.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-03-31 | $0.50B   | 63.12%        |
| 2024-12-31 | $0.48B   | 62.94%        |
| 2024-09-30 | $0.44B   | 61.79%        |
| 2024-06-30 | $0.41B   | 58.83%        |
| 2024-03-31 | $0.37B   | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity   | ROE      |
|------------|----------|----------|
| 2025-03-31 | $1.24B   | -5.40%   |
| 2024-12-31 | $1.20B   | -4.50%   |
| 2024-09-30 | $0.88B   | -3.60%   |
| 2024-06-30 | $0.84B   | -4.48%   |
| 2024-03-31 | $0.79B   | -8.51%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue is consistently increasing over the past few quarters, and the profit margin is strong and also increasing. This is a positive sign.
*   **Capital and Profitability:** Equity is increasing, suggesting the company is building its asset base. However, the Return on Equity (ROE) is negative, reflecting the losses being incurred despite the revenue growth.

**7. Overall Summary:**

Natera Inc. (NTRA) presents a mixed picture.

*   **Positives:** Strong revenue growth, increasing profit margins, high potential long-term return (though to be viewed cautiously), recent positive price momentum, and a relatively low Market Risk Indicator.
*   **Negatives:** Consistent losses (negative EPS and ROE), high historical volatility (high MDD), RSI approaching overbought territory, and recent news indicating potentially disruptive events.

**Conclusion:** NTRA appears to be a high-growth, high-risk stock. The company has demonstrated the ability to generate revenue and increase profit margins, but it has yet to achieve profitability. The recent positive price momentum and high expected return may be attractive to some investors, but the risks should be carefully considered. Further research into the specific events mentioned in the recent news is essential before making any investment decision. It is important to consider the high volatility and consistent losses before investing. The Hybrid signal recommends only buying 80% of available cash.
